Upper GI polyposis and cancer in FAP: diagnosis, surveillance and treatment.
Upper GI polyposis and cancer in FAP: diagnosis, surveillance and treatment. Fam Cancer. 2025 May 26; 24(2):49.
PMID: 40418521
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes.
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes. Virchows Arch. 2025 May 13.
PMID: 40358740
Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer.
Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer. J Natl Compr Canc Netw. 2025 04; 23(4).
PMID: 40203872
Genomic and cellular responses to aspirin in colonic organoids from African- and European-Americans.
Genomic and cellular responses to aspirin in colonic organoids from African- and European-Americans. Physiol Genomics. 2025 Mar 01; 57(3):103-114.
PMID: 39812338
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2024 12; 22(10):695-711.
PMID: 39689429
Anticipation in families with MLH1-associated Lynch syndrome.
Anticipation in families with MLH1-associated Lynch syndrome. Cancer. 2025 Jan 01; 131(1):e35589.
PMID: 39435727
Germline CDH1 Variants and Lifetime Cancer Risk.
Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024 09 03; 332(9):722-729.
PMID: 38873722
Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma.
Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma. Arch Pathol Lab Med. 2024 Jun 01; 148(6):728-734.
PMID: 37708308
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer. 2024 Oct 01; 130(19):3297-3304.
PMID: 38809542
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. J Natl Compr Canc Netw. 2024 04; 22(3):158-166.
PMID: 38626807